In the guidelines, CDC recommends that antibody tests not be
used, at this time, to make policy decisions or to determine if an
individual has immunity to
COVID-19.
On May 26, 2020, the Centers for Disease Control and Prevention
(CDC) issued interim
guidelines for COVID-19 antibody testing in clinical and
public health laboratories. The guidelines contain recommendations
for clinical and public health laboratories regarding: 1) choice of
test and testing strategy; 2) individuals who test positive for
COVID-19 antibodies; and 3) additional considerations on the use of
antibody tests.
In the guidelines, CDC recommends that antibody tests not be
used, at this time, to make policy decisions or to determine if an
individual has immunity to COVID-19. Over time, these tests should
be able to help determine the proportion of a population previously
infected with COVID-19 and provide information about populations
that may have certain levels of immunity and potentially
